OncoGenex Pharmaceuticals to Release Second Quarter 2009 Financial Results



    BOTHELL, WA and VANCOUVER, Aug. 3 /CNW/ - OncoGenex Pharmaceuticals
(NASDAQ:   OGXI) announced today that the Company will announce second quarter
financial results on Thursday, August 6, 2009. OncoGenex will host a
conference call and live webcast at 4:30 p.m. EDT that afternoon to discuss
quarterly results.
    The webcast can be accessed on the Investor Relations page of the
OncoGenex Web site at www.oncogenex.com. Alternatively, you may access the
live conference call by dialing 877-548-7912 (U.S. & Canada) or 719-325-4897
(International). A webcast replay will be available approximately two hours
after the call and will be archived on www.oncogenex.com for 90 days.

    About OncoGenex Pharmaceuticals

    OncoGenex is a biopharmaceutical company committed to the development and
commercialization of new therapies that address unmet needs in the treatment
of cancer. OncoGenex has a deep oncology pipeline, with each product candidate
having a distinct mechanism of action and representing a unique opportunity
for cancer drug development. OGX-011, the lead candidate that has completed
five Phase 2 clinical trials in prostate, lung and breast cancers, is designed
to inhibit the production of a specific protein associated with treatment
resistance; OGX-427 is in Phase 1 clinical development; SN2310 has completed
the Phase 1 clinical trial; and CSP-9222 and OGX-225 are currently in
pre-clinical development. More information about OncoGenex is available at
www.oncogenex.com.





For further information:

For further information: OncoGenex Contact: Scott Cormack, President &
CEO, (604) 736-3678, scormack@oncogenex.com; Media and Investor Contact: Jason
Spark, Porter Novelli Life Sciences, (619) 849-6005,
jspark@pnlifesciences.com


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890